Gene · 92521
Papers3,158
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 3,158
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| SARS-CoV-2 epitope-specific T cells: Immunity response feature, TCR repertoire characteristics and cross-reactivity. | Front Immunol | 2023 | 36969254 | PubTator, text mining | PubMed |
| An in-solution snapshot of SARS-COV-2 main protease maturation process and inhibition. | Nat Commun | 2023 | 36941262 | PubTator, text mining | PubMed |
| Genetic conservation across SARS-CoV-2 non-structural proteins - Insights into possible targets for treatment of future viral outbreaks. | Virology | 2023 | 36940641 | PubTator, text mining | PubMed |
| Therapeutic developments for SARS-CoV-2 infection-Molecular mechanisms of action of antivirals and strategies for mitigating resistance in emerging variants in clinical practice. | Front Microbiol | 2023 | 36937282 | PubTator, text mining | PubMed |
| A central chaperone-like role for 14-3-3 proteins in human cells. | Mol Cell | 2023 | 36931259 | PubTator, text mining | PubMed |
| Comparative mutational analysis of the Zika virus genome from different geographical locations and its effect on the efficacy of Zika virus-specific neutralizing antibodies. | Front Microbiol | 2023 | 36910181 | PubTator, text mining | PubMed |
| Ovatodiolide inhibits SARS-CoV-2 replication and ameliorates pulmonary fibrosis through suppression of the TGF-β/TβRs signaling pathway. | Biomed Pharmacother | 2023 | 36906971 | PubTator, text mining | PubMed |
| Epigenetic perspectives associated with COVID-19 infection and related cytokine storm: an updated review. | Infection | 2023 | 36906872 | PubTator, text mining | PubMed |
| Porcine Epidemic Diarrhea Virus and Its nsp14 Suppress ER Stress Induced GRP78. | Int J Mol Sci | 2023 | 36902365 | PubTator, text mining | PubMed |
| COVID-19 Biogenesis and Intracellular Transport. | Int J Mol Sci | 2023 | 36901955 | PubTator, text mining | PubMed |
| Lessons Learnt from COVID-19: Computational Strategies for Facing Present and Future Pandemics. | Int J Mol Sci | 2023 | 36901832 | PubTator, text mining | PubMed |
| SARS-CoV-2 Mutations Lead to a Decrease in the Number of Tissue-Specific MicroRNA-Binding Regions in the Lung. | Bull Exp Biol Med | 2023 | 36899205 | PubTator, text mining | PubMed |
| The SARS-CoV-2 main protease induces neurotoxic TDP-43 cleavage and aggregates. | Signal Transduct Target Ther | 2023 | 36894543 | PubTator, text mining | PubMed |
| SARS-CoV-2-encoded small RNAs are able to repress the host expression of SERINC5 to facilitate viral replication. | Front Microbiol | 2023 | 36876111 | PubTator, text mining | PubMed |
| Biomolecular condensates: Formation mechanisms, biological functions, and therapeutic targets. | MedComm (2020) | 2023 | 36875159 | PubTator, text mining | PubMed |
| Molecular-evaluated and explainable drug repurposing for COVID-19 using ensemble knowledge graph embedding. | Sci Rep | 2023 | 36871056 | PubTator, text mining | PubMed |
| SARS-Cov-2 Infection and Seroconversion Rates in Healthcare Providers Prior to COVID-19 Vaccine Rollout. | Biol Res Nurs | 2023 | 36869766 | PubTator, text mining | PubMed |
| Global Dynamics of Porcine Enteric Coronavirus PEDV Epidemiology, Evolution, and Transmission. | Mol Biol Evol | 2023 | 36869744 | PubTator, text mining | PubMed |
| An insight overview on COVID-19 mRNA vaccines: Advantageous, pharmacology, mechanism of action, and prospective considerations. | Int Immunopharmacol | 2023 | 36867924 | PubTator, text mining | PubMed |
| Antitarget, Anti-SARS-CoV-2 Leads, Drugs, and the Drug Discovery-Genetics Alliance Perspective. | J Med Chem | 2023 | 36857133 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/92521/papers?page=26